{"id":"NCT01985425","sponsor":"Population Health Research Institute","briefTitle":"Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study","officialTitle":"Colchicine For Prevention of Perioperative Atrial Fibrillation in Patients Undergoing Thoracic Surgery Pilot Study.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-04","primaryCompletion":"2015-04","completion":"2015-09","firstPosted":"2013-11-15","resultsPosted":"2017-01-23","lastUpdate":"2021-11-05"},"enrollment":100,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Atrial Fibrillation","Thoracic Surgery"],"interventions":[{"type":"DRUG","name":"Colchicine 0.6 mg","otherNames":["Brand names: PMS Colchicine, Colchicine TAB 0.6 mg"]},{"type":"DRUG","name":"Placebo Colchicine","otherNames":[]}],"arms":[{"label":"Active Colchicine","type":"EXPERIMENTAL"},{"label":"Placebo Colchicine","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this pilot study is to determine the feasibility of comparing colchicine to placebo for the prevention of new onset atrial fibrillation in patients undergoing general thoracic surgery and establish the foundation for a large, multi-centre, clinical trial.","primaryOutcome":{"measure":"Clinically Significant Atrial Fibrillation","timeFrame":"Post-operative Day 1 until Postoperative Day 30","effectByArm":[{"arm":"Active Colchicine","deltaMin":5,"sd":null},{"arm":"Placebo Colchicine","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"55 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":3},"locations":{"siteCount":2,"countries":["Canada"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":49},"commonTop":[]}}